Literature DB >> 15341481

Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.

Steffen Renner1, Gisbert Schneider.   

Abstract

A pharmacophore-based approach for compiling focused screening libraries is presented. It integrates information from three-dimensional molecular alignments into correlation vector-based database screening. The pharmacophore model is represented by a number of spheres of Gaussian-distributed feature densities. Different degrees of "fuzziness" can be introduced to influence the model's resolution. Transformation of this pharmacophore representation into a correlation vector results in a vector of feature probabilities which can be utilized for rapid virtual screening of compound databases or virtual libraries. The approach was validated by retrospective screening for cyclooxygenase 2 (COX-2) and thrombin ligands. A variety of models with different degrees of fuzziness were calculated and tested for both classes of molecules. Best performance was obtained with pharmacophore models reflecting an intermediate degree of fuzziness, yielding an enrichment factor of up to 39 for the first 1% of the ranked database. Appropriately weighted fuzzy pharmacophore models performed better in retrospective screening than similarity searching using only a single query molecule. The new pharmacophore method was shown to complement existing approaches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341481     DOI: 10.1021/jm031139y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Molecular similarity and diversity in chemoinformatics: from theory to applications.

Authors:  Ana G Maldonado; J P Doucet; Michel Petitjean; Bo-Tao Fan
Journal:  Mol Divers       Date:  2006-02       Impact factor: 2.943

2.  Feature-map vectors: a new class of informative descriptors for computational drug discovery.

Authors:  Gregory A Landrum; Julie E Penzotti; Santosh Putta
Journal:  J Comput Aided Mol Des       Date:  2007-01-05       Impact factor: 3.686

3.  Molecular modeling study on chemically diverse series of cyclooxygenase-2 selective inhibitors: generation of predictive pharmacophore model using catalyst.

Authors:  Madhu Chopra; Ruby Gupta; Swati Gupta; Daman Saluja
Journal:  J Mol Model       Date:  2008-07-30       Impact factor: 1.810

4.  Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.

Authors:  Sivakumar Prasanth Kumar
Journal:  J Mol Model       Date:  2018-09-15       Impact factor: 1.810

5.  The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.

Authors:  L Fischer; M Hornig; C Pergola; N Meindl; L Franke; Y Tanrikulu; G Dodt; G Schneider; D Steinhilber; O Werz
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

6.  TrixX: structure-based molecule indexing for large-scale virtual screening in sublinear time.

Authors:  Ingo Schellhammer; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2007-02-09       Impact factor: 4.179

7.  Snooker structure-based pharmacophore model explains differences in agonist and blocker binding to bitter receptor hTAS2R39.

Authors:  Wibke S U Roland; Marijn P A Sanders; Leo van Buren; Robin J Gouka; Harry Gruppen; Jean-Paul Vincken; Tina Ritschel
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

8.  Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design.

Authors:  Lukas Friedrich; Gino Cingolani; Ying-Hui Ko; Mariaclara Iaselli; Morena Miciaccia; Maria Grazia Perrone; Konstantin Neukirch; Veronika Bobinger; Daniel Merk; Robert Klaus Hofstetter; Oliver Werz; Andreas Koeberle; Antonio Scilimati; Gisbert Schneider
Journal:  Adv Sci (Weinh)       Date:  2021-06-27       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.